Biological Insights into Myeloma and Other B Cell Malignancies

by Mariateresa Fulciniti, Nicola Amodio, Michele Cea, Patricia Maiso, Abdel Kareem Azab
Published 2016-01-01

Selinexor Overcomes Hypoxia-Induced Drug Resistance in Multiple Myeloma

by Barbara Muz, Feda Azab, Pilar de la Puente, Yosef Landesman, Abdel Kareem Azab
Published 2017-08-01

CD47-targeting antibodies as a novel therapeutic strategy in hematologic malignancies

by Jennifer Sun, Yixuan Chen, Berit Lubben, Ola Adebayo, Barbara Muz, Abdel Kareem Azab
Published 2021-01-01

Synthesis and Characterisation of a Boron-Rich Symmetric Triazine Bearing a Hypoxia-Targeting Nitroimidazole Moiety

by Tobias Hartwig Bünning, Luigi Panza, Abdel Kareem Azab, Barbara Muz, Silvia Fallarini, Daniela Imperio
Published 2021-01-01

Targeting E-Selectin to Tackle Cancer Using Uproleselan

by Barbara Muz, Anas Abdelghafer, Matea Markovic, Jessica Yavner, Anupama Melam, Noha Nabil Salama, Abdel Kareem Azab
Published 2021-01-01

Drug Delivery Approaches for the Treatment of Cervical Cancer

by Farideh Ordikhani, Mustafa Erdem Arslan, Raymundo Marcelo, Ilyas Sahin, Perry Grigsby, Julie K. Schwarz, Abdel Kareem Azab
Published 2016-07-01

Inhibition of P-Selectin and PSGL-1 Using Humanized Monoclonal Antibodies Increases the Sensitivity of Multiple Myeloma Cells to Bortezomib

by Barbara Muz, Feda Azab, Pilar de la Puente, Scott Rollins, Richard Alvarez, Ziad Kawar, Abdel Kareem Azab
Published 2015-01-01

Bispecific T Cell Engagers for the Treatment of Multiple Myeloma: Achievements and Challenges

by Kinan Alhallak, Jennifer Sun, Amanda Jeske, Chaelee Park, Jessica Yavner, Hannah Bash, Berit Lubben, Ola Adebayo, Ayah Khaskiah, Abdel Kareem Azab
Published 2021-06-01

A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myeloma

by Kinan Alhallak, Amanda Jeske, Pilar de la Puente, Jennifer Sun, Mark Fiala, Feda Azab, Barbara Muz, Ilyas Sahin, Ravi Vij, John F. DiPersio, Abdel Kareem Azab
Published 2021-09-01

Targeting CD47 as a Novel Immunotherapy for Multiple Myeloma

by Jennifer Sun, Barbara Muz, Kinan Alhallak, Matea Markovic, Shannon Gurley, Zhe Wang, Nicole Guenthner, Katherine Wasden, Mark Fiala, Justin King, Daniel Kohnen, Noha Nabil Salama, Ravi Vij, Abdel Kareem Azab
Published 2020-01-01

Novel tumor suppressor function of glucocorticoid-induced TNF receptor GITR in multiple myeloma.

by Yang Liu, Phong Quang, Esteban Braggio, Hai Ngo, Gayane Badalian-Very, Ludmila Flores, Yong Zhang, Antonio Sacco, Patricia Maiso, Abdel Kareem Azab, Feda Azab, Ruben Carrasco, Barrett J Rollins, Aldo M Roccaro, Irene M Ghobrial
Published 2013-01-01

The Non-Coding RNA Landscape of Plasma Cell Dyscrasias

by Eugenio Morelli, Annamaria Gullà, Roberta Rocca, Cinzia Federico, Lavinia Raimondi, Stefano Malvestiti, Valter Agosti, Marco Rossi, Giosuè Costa, Gianluca Giavaresi, Abdel Kareem Azab, Antonia Cagnetta, Michele Cea, Pierosandro Tagliaferri, Antonino Neri, Nikhil C. Munshi, Giuseppe Viglietto, Pierfrancesco Tassone, Nicola Amodio
Published 2020-01-01

Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma

by Cinzia Federico, Kinan Alhallak, Jennifer Sun, Kathleen Duncan, Feda Azab, Gail P. Sudlow, Pilar de la Puente, Barbara Muz, Vaishali Kapoor, Luna Zhang, Fangzheng Yuan, Matea Markovic, Joseph Kotsybar, Katherine Wasden, Nicole Guenthner, Shannon Gurley, Justin King, Daniel Kohnen, Noha N. Salama, Dinesh Thotala, Dennis E. Hallahan, Ravi Vij, John F. DiPersio, Samuel Achilefu, Abdel Kareem Azab
Published 2020-11-01